Cargando…

Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review

PURPOSE: To systematically estimate the patient-reported outcomes (PROs) and economic burden of sickle cell disease (SCD) among adults in the United States (US). PATIENTS AND METHODS: Two systematic literature reviews (SLRs), one each for the PROs and economic topics, were performed using MEDLINE an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Soyon, Vania, Diana K, Bhor, Menaka, Revicki, Dennis, Abogunrin, Seye, Sarri, Grammati
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354084/ https://www.ncbi.nlm.nih.gov/pubmed/32753936 http://dx.doi.org/10.2147/IJGM.S257340

Ejemplares similares

Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease
por: Sarri, Grammati, et al.
Publicado: (2018)

Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review
por: Martin, Alison, et al.
Publicado: (2014)

Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study
por: Shah, Nirmish, et al.
Publicado: (2019)

Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study
por: Shah, Nirmish, et al.
Publicado: (2019)

High Healthcare Utilization in Adolescents with Sickle Cell Disease Prior to Transition to Adult Care: A Retrospective Study
por: Kanter, Julie, et al.
Publicado: (2019)

Sickle cell disease complications: Prevalence and resource utilization
por: Shah, Nirmish, et al.
Publicado: (2019)

Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review
por: Thompson, Juliette C., et al.
Publicado: (2022)

P1704: PROJECTED LIFETIME ECONOMIC BURDEN OF SEVERE SICKLE CELL DISEASE IN THE UNITED STATES
por: Udeze, C., et al.
Publicado: (2022)

Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study
por: Shah, Nirmish, et al.
Publicado: (2020)

Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

1145. Meningococcal B Immunization for Adolescents in the Presence of Added Gonorrhea Protection: A Public Health Impact Modelling Study in the United States
por: Kocaata, Zeki, et al.
Publicado: (2023)

Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

The economic and humanistic burden of bipolar disorder in adults in the United States
por: Dembek, Carole, et al.
Publicado: (2023)

Economic burden of sickle cell disease in Brazil
por: Silva-Pinto, Ana Cristina, et al.
Publicado: (2022)

Can Real-World Evidence Help Restore Decades of Health Inequalities by Informing Health Care Decision-Making? Certainly, and Here is How
por: Sarri, Grammati
Publicado: (2022)

The Economic Burden of Adults with Major Depressive Disorder in the United States (2019)
por: Greenberg, Paul, et al.
Publicado: (2023)

Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
por: Muthukumar, Madhusubramanian, et al.
Publicado: (2017)

AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis
por: Abogunrin, Seye, et al.
Publicado: (2015)

Economic Burden of Sanfilippo Syndrome in the United States
por: Ashby, Frederick, et al.
Publicado: (2023)

Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based Study
por: Kang, Hyeun Ah, et al.
Publicado: (2020)

Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study
por: Kang, Hyeun Ah, et al.
Publicado: (2020)

Health State Utility Values in Early-Stage Non-small Cell Lung Cancer: A Systematic Literature Review
por: Jovanoski, Nick, et al.
Publicado: (2023)

Global prevalence of long-term neurodevelopmental impairment following extremely preterm birth: a systematic literature review
por: Sarda, Sujata P., et al.
Publicado: (2021)

The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)
por: Greenberg, Paul E., et al.
Publicado: (2021)

The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
por: Bessonova, Leona, et al.
Publicado: (2020)

Economic Burden of Urgency Urinary Incontinence in the United States: A Systematic Review
por: Coyne, Karin S., et al.
Publicado: (2014)

The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease
por: Rizio, Avery A., et al.
Publicado: (2020)

Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom
por: Abogunrin, Seye, et al.
Publicado: (2015)

Economic Burden of West Nile Virus in the United States
por: Barrett, Alan D. T.
Publicado: (2014)

The Economic Burden of Obesity by Glycemic Stage in the United States
por: Li, Qian, et al.
Publicado: (2015)

The potential economic burden of Zika in the continental United States
por: Lee, Bruce Y., et al.
Publicado: (2017)

Economic Burden of Legionnaires’ Disease, United States, 2014
por: Baker-Goering, Madeleine, et al.
Publicado: (2021)

Moderately severe and severe acute pancreatitis : a systematic review of the outcomes in the USA and European Union-5
por: Sarri, Grammati, et al.
Publicado: (2019)

Treatment patterns and burden of complications associated with sickle cell disease: A US retrospective claims analysis
por: Manwani, Deepa, et al.
Publicado: (2022)

The Projected Economic and Health Burden of Uncontrolled Asthma in the United States
por: Yaghoubi, Mohsen, et al.
Publicado: (2019)

Regarding “The Clinical and Economic Burden of Norovirus Gastroenteritis in the United States”
por: Do, Steven R, et al.
Publicado: (2021)

The national economic burden of rare disease in the United States in 2019
por: Yang, Grace, et al.
Publicado: (2022)

The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United States
por: Woolley, Michael, et al.
Publicado: (2022)

Economic Burden of Postoperative Ileus Associated With Colectomy in the United States
por: Iyer, Shrividya, et al.
Publicado: (2009)

Economic burden of pediatric prescription opioid poisonings in the United States
por: Patel, Anisha M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mt5iobq6mr7khommhh39pqr77v